Atara Biotherapeutics, Inc. (ATRA) Cash flow
Market cap
$27.72M
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 10 | 10 | 17 | 23 | 34 | 52 | 51 | 54 | 54 | 45 | 27 |
| Cash from operations | -17 | -37 | -60 | -88 | -180 | -236 | -181 | -221 | -270 | -193 | -69 |
| Capital expenditures | -0 | -0 | -3 | -20 | -36 | -6 | -5 | -11 | -4 | -1 | -0 |
| Cash from investing | -83 | -220 | 84 | 99 | -196 | 60 | -121 | 22 | 203 | 124 | 9 |
| Cash from financing | 70 | 259 | 1 | 20 | 358 | 189 | 428 | 104 | 53 | 2 | 59 |
| Free cash flow | |||||||||||
| FCF margin (%) | - | - | - | - | - | - | - | - | - |